CHICAGO , Aug. 7, 2024 /PRNewswire/ -- The global In Vitro Fertilization Market is expected to grow from USD 949 million in 2024 to USD 1,650 million by 2029, at a CAGR of 11.7%.
The global in vitro fertilization (IVF) market is driven by rising infertility rates, older maternal age, increased funding, and advancements in IVF techniques. Despite high costs and strict regulations potentially hindering growth, ongoing innovations in health technology and improved healthcare infrastructure in developing countries are likely to boost demand. Opportunities in IVF are expanding, particularly in developing nations where growing affluence and better healthcare access support fertility treatments.
However, challenges include decreased treatment effectiveness in older women and associated risks like OHSS and multiple pregnancies. The IVF equipment segment is expected to lead the market, with fertility clinics and IVF centers being the primary end-users. Asia-Pacific is anticipated to experience the highest growth due to an aging population and advanced medical technologies.
Key market players include CooperSurgical, Vitrolife, Cook Medical, and others, with the region benefiting from demographic and economic trends driving market expansion..
